You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

designed ankyrin repeat protein (DARPin®)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Breast Cancer Trial (SPECT)

Not yet recruiting
  • Primary Breast Cancer
  • (no location specified)
Jun 19, 2023

Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)

Enrolling by invitation
  • Breast Cancer Female
  • Tomsk, Russian Federation
    Olga
Jun 19, 2023

Advanced Malignant Solid Tumor Trial in France, Netherlands (MP0317, a tri-specific fibroblast activation protein (FAP) x CD40

Recruiting
  • Advanced Malignant Solid Tumor
  • MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate
  • Lyon, Cedex 08, France
  • +3 more
Nov 4, 2022

Primary Breast Cancer Trial in Tomsk (SPECT)

Completed
  • Primary Breast Cancer
  • Tomsk, Russian Federation
    TomskNRMC
Oct 4, 2021

COVID-19 Trial in London (Ensovibep, Placebo)

Terminated
  • COVID-19
  • London, United Kingdom
    HMR
Mar 3, 2022

COVID-19 Trial in Worldwide (MP0420, Placebo, Remdesivir)

Active, not recruiting
  • COVID-19
  • Tucson, Arizona
  • +104 more
Mar 22, 2023

Advanced Solid Tumor Trial in Lyon, Toulouse, Villejuif (MP0310 (AMG 506))

Recruiting
  • Advanced Solid Tumor
  • MP0310 (AMG 506)
  • Lyon, France
  • +2 more
Dec 21, 2021

Hepatitis B, Chronic Trial in Worldwide (IMC-I109V-101 Single Ascending Dose, IMC-I109V-101 Multiple Ascending Doses)

Recruiting
  • Hepatitis B, Chronic
  • IMC-I109V-101 Single Ascending Dose
  • IMC-I109V-101 Multiple Ascending Doses
  • Los Angeles, California
  • +19 more
May 10, 2023

Healthy Trial in Oxford (10 g NUTRALYS®S85 Plus pea protein, 20 g NUTRALYS®S85 Plus pea protein, 10 g Whey protein concentrate)

Completed
  • Healthy
  • 10 g NUTRALYS®S85 Plus pea protein
  • +4 more
  • Oxford, United Kingdom
    Oxford Brookes Centre for Nutrition and Health
Sep 5, 2022

Observatory on Cow's Milk Protein Allergy

Not yet recruiting
  • Food Allergy
  • Pepticate® Syneo®
  • Paris, France
    Hôpital Trousseau - APHP
Oct 10, 2023

Malaria Trial in Baltimore (MAM01, Placebo)

Not yet recruiting
  • Malaria
  • MAM01
  • Placebo
  • Baltimore, Maryland
    Center for Vaccine Development and Global Health, 685 W. Baltimo
May 26, 2023

Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

Not yet recruiting
  • Bronchial and Thymic Neuroendocrine Tumour
  • +3 more
  • Lu-177 DOTATATE (Lutathera®)
  • (no location specified)
Nov 1, 2023

Postoperative Pain, Cesarean Section Trial in Charlotte (Liposomal bupivacaine, Bupivacaine HCl)

Suspended
  • Postoperative Pain
  • Cesarean Section
  • Liposomal bupivacaine
  • Bupivacaine HCl
  • Charlotte, North Carolina
    Atrium Health
Jan 27, 2023

Cardiovascular Diseases Trial in Rochester (Peer Coach)

Enrolling by invitation
  • Cardiovascular Diseases
  • Peer Coach
  • Rochester, New York
    University of Rochester
Jun 27, 2023

COVID-19 Trial in Worldwide (ensovibep, Placebo)

Terminated
Has Results
  • COVID-19
  • Jasper, Alabama
  • +47 more
Dec 21, 2022

Breast Cancer Female Trial in Tomsk (99mTc-ADAPT6, 99mTc-DARPinG3)

Recruiting
  • Breast Cancer Female
  • Tomsk, Russian Federation
    Tomsk NRMC
May 12, 2022

Molecular Imaging in HER2-positive Breast Cancer During

Enrolling by invitation
  • HER2-positive Breast Cancer
  • Female
  • Tomsk, Russian Federation
  • +1 more
Jun 7, 2022

DM1 Patients in China

Enrolling by invitation
  • Myotonic Dystrophy 1
  • Brain MRI scan
  • Shanghai, China
    Huashan Hospital
Oct 20, 2023

Fever, Child, Only Trial in Bartin (discharge instructions with pamphlet, discharge instructions with video, verbal discharge

Recruiting
  • Fever
  • Child, Only
  • discharge instructions with pamphlet
  • +2 more
  • Bartın, Turkey
    Bartin Maternity and Pediatrics Hospital
Jun 26, 2023

Tumors Trial in Germany, Switzerland, United Kingdom (MP0274)

Completed
  • Neoplasms
  • Frankfurt, Germany
  • +3 more
Jan 6, 2022

COVID-19 Trial (SARS-CoV-2 Subunit Recombinant Protein Vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Subunit Recombinant Protein Vaccine
  • (no location specified)
Jul 5, 2023

Colonic Disease, Adherence, Patient Trial (Written recommendation)

Not yet recruiting
  • Colonic Disease
  • Adherence, Patient
  • Written recommendation
  • (no location specified)
Feb 2, 2023

Drug-drug Interaction Study Trial in Hyderabad (SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole

Completed
  • Drug-drug Interaction Study
  • SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg
  • Hyderabad, India
    QPS Bioserve India Pvt Limited
Nov 20, 2023

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (Eversense® CGM system)

Active, not recruiting
  • Diabetes Mellitus
  • +2 more
  • Eversense® CGM system
  • Newport Beach, California
  • +16 more
Mar 31, 2022

Refractory Solid Tumor Trial in Xiamen (177Lu-DOTA-EB-FAPI radionuclide therapy)

Recruiting
  • Refractory Solid Tumor
  • 177Lu-DOTA-EB-FAPI radionuclide therapy
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
Jul 26, 2023